SCHEMBL18175070

SCHEMBL18175070

CC(C(=O)Nc1cccc(C(F)(F)F)c1)n1cnc2[nH]c(=O)n(C)c(=O)c21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 3/20 0.50
RXFP1 Q9HBX9 1/20 0.49
TRPA1 O75762 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
IKBKB O14920 1/20 0.41
KCNJ6 P48051 1/20 0.41
KCNJ5 P48544 1/20 0.41
KCNJ3 P48549 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18175081 0.87 ALDH1A1 (0.43) BRAFTRPA1KMT2AMEN1TSHR
SCHEMBL10114284 0.85 RXFP1 (0.66) RXFP1TRPA1SMN1; SMN2MAPT
SCHEMBL14754387 0.81 RXFP1 (0.72) BRAFRXFP1KMT2AMEN1TSHR
SCHEMBL12584325 0.78 RXFP1 (0.58) RXFP1TRPA1
SCHEMBL3038555 0.76 KDR (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL3043306 0.74 MAPK1 (0.46) KMT2AMEN1TSHRSMN1; SMN2ALDH1A1
SCHEMBL17210350 0.74 ALDH1A1 (0.57) TRPA1TSHRALDH1A1CYP3A4KDM4E
SCHEMBL17210341 0.72 ALDH1A1 (0.55) TRPA1KMT2ATSHRALDH1A1POLB
SCHEMBL10114323 0.70 PORCN (0.61) RXFP1TRPA1KMT2AMEN1SMN1; SMN2
SCHEMBL5561958 0.70 SMN1; SMN2 (0.63) KMT2AMEN1SMN1; SMN2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 EP disclosed